News

Natrol Examines Sleep Issues Among Women: Key Insights Revealed

Natrol Examines Sleep Issues Among Women: Key Insights Revealed

Understanding Sleep Problems Among Women

Natrol, a leader in the sleep aid market, unveils significant insights from its latest Sleep Spiral Survey. This research highlights the serious challenges women, particularly those aged 40 to 60, face regarding sleep. According to the findings, nearly half of these women report losing up to two hours of sleep nightly due to racing thoughts. Alarmingly, 10% struggle with loss of four or more hours of sleep each night.

Identifying the Causes of Sleeplessness

Sleep disturbances are a pressing concern for women today, who balance the demands of family, work, and personal well-being. Rebekah Lyle, the Chief Marketing Officer at Natrol, expressed understanding of the multifaceted pressures faced by women. These pressures often lead to overthinking, resulting in a downward spiral of sleepless nights that leave them feeling fatigued the next day.

Key Findings from the Survey

The survey conducted by Natrol aimed to investigate the underlying factors contributing to sleep deprivation among women. The results were telling. A staggering 72% of surveyed women admitted to difficulties in falling asleep, with 87% indicating they struggle to maintain sleep throughout the night.

Women Continuing to Face Sleepless Nights

Among the findings, one-third of respondents disclosed that their sleep issues have worsened over the past year, while more than half felt their sleep quality has remained stagnant. Only a small fraction, merely 13%, reported improvements in their sleeping patterns.

Financial Stress as a Primary Factor

Notably, financial worries are a significant contributor to sleeplessness, as indicated by half of the participants who identified this as their primary stressor affecting their ability to fall asleep. The situation is alarming—many women are resorting to surrendering their attempts to sleep because of overwhelming thoughts and anxieties.

Seeking Solutions for Better Sleep

With the revelations from the Sleep Spiral Survey, it's clear that women require effective strategies to manage their sleep issues. As a response to these findings, Natrol aims to provide informative resources and product options to support improved sleep quality. Their portfolio includes various sleep solutions available on Amazon and in stores. Through these, women can hopefully learn to sleep better and reduce nightly stressors.

Natrol's Commitment to Women's Health

Natrol is dedicated to enhancing consumer wellness and intends to utilize the insights from this survey to develop solutions tailored to meet the needs of women. The brand is focused on helping individuals regain control over their sleep and ultimately improve their overall health and well-being.

About Natrol LLC

Founded in 1980, Natrol has developed a reputation as a trusted name in the health supplement industry. Throughout the years, it has built its product line to include key areas critical to health: Sleep, Immunity, Brain Health, Mood & Stress, and Beauty. As the #1 brand for melatonin in the United States, Natrol is committed to providing high-quality products to over 40 countries worldwide, empowering consumers to lead healthier lives.

Frequently Asked Questions

What is the main finding from Natrol’s Sleep Spiral Survey?

The survey found that nearly 50% of women aged 40-60 lose significant sleep due to spiraling thoughts.

How does financial stress impact sleep according to the survey?

Financial worries were identified by 50% of respondents as a significant factor preventing them from falling asleep.

What age group did the Natrol Survey focus on?

The survey specifically targeted women ages 40 to 60.

What initiatives is Natrol considering to help women sleep better?

Natrol plans to provide actionable resources and a range of sleep aid products to help women manage their sleep challenges.

Where can consumers find Natrol's sleep products?

Natrol's products are available for purchase on Amazon, as well as various retailers across the country.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 2

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 6

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 3

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 4

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 6

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 7

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 2

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading

Top 5 Most Recently Viewed Articles

SKK Holdings Limited Announces Pricing for Share IPO Offering

Updated Category News Views 65

SKK Holdings Limited Announces Share Pricing for IPO SKK Holdings Limited (“SKK” or the “Company”) (Nasdaq: SKK), a specialized civil engineering service provider in subsurface utility works, has proudly announced the pricing of its initial public offering. The Company will offer 2,500,000 ordinary shares at a public offering price of $4.00 per share, yielding...

Continue Reading
Antelope Enterprise: Financial Performance Insights for 2024

Updated Category News Views 149

Antelope Enterprise Holdings Limited (NASDAQ: AEHL) hit the financial report stage hard back in mid-2024, flaunting numbers that tell quite the tale of both triumphs and tribulations. This company was hustling across two growing fronts: the fast-paced world of livestreaming ecommerce and the burgeoning energy sector down in Texas. Their half-year performance review...

Continue Reading
Olivier Falut Steps Into CFO Role at EUROAPI to Drive Growth

Updated Category News Views 344

Olivier Falut Joins EUROAPI as the New Chief Financial Officer EUROAPI is excited to announce the appointment of Olivier Falut as its new Chief Financial Officer, effective immediately. Olivier will be an integral member of the Executive Committee, succeeding Evelyne Nguyen. Evelyne will ensure continuity and a smooth transition within the company through her support...

Continue Reading
OPEXUS and Casepoint Join Forces for Growth and Innovation

Updated Category News Views 261

OPEXUS and Casepoint Unite for Strategic Growth In a significant development in the technology sector, OPEXUS, a frontrunner in government process management software, and Casepoint, an innovator in data discovery technology, have announced their merger. This significant move comes along with a majority investment from Thoma Bravo, a renowned software investment firm...

Continue Reading
MeiraGTx Holdings: An In-Depth Look at Future Potential

Updated Category News Views 69

MeiraGTx Holdings plc (NASDAQ:MGTX) was a clinical-stage gene therapy firm making waves back in 2024. The company announced a pivotal financial move, securing $50 million through equity financing at $4 per share, largely thanks to a $30 million investment from Sanofi (NYSE:SNY). While this funding boosted MGTX’s war chest, traders were already whispering about the heavy...

Continue Reading